Diabetes Clinical Trials in Chicago

Showing 261-280 of 574 trials

Impact of No-carrageenan Diet on Glucose Tolerance in Prediabetes

NCT02720393

Participants will be randomly assigned to either regular or no-carrageenan prepared diets to determine whether the no-carrageenan leads to improvement in glucose tolerance. Hemoglobin A1c is the primary outcome measure.

Prediabetes

University of Illinois at Chicago48 participantsStarted Feb 2016

Chicago, Illinois, United States

COMPLETEDPhase 32.2 miles

Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD

NCT00157339

Phase 3 , open-label, randomized study to evaluate the safety and efficacy of the Lilly/Alkermes inhaled insulin system compared to injected insulin in type 1 and type 2 diabetes patients with asthma or COPD. Patients will be treated for 12 months with a 2 month follow up period.

Diabetes MellitusAsthmaPulmonary Disease, Chronic Obstructive

Eli Lilly and Company299 participantsStarted Aug 2005

Montgomery, Alabama, United States • Burbank, California, United States • Greenbrae, California, United States +98 more locations

Impact of No-carrageenan Diet on Glucose Tolerance in Prediabetes

Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD

Diabetes Trials in Other Cities

A Study to Evaluate the Effect of Dapagliflozin With and Without Saxagliptin on Albuminuria, and to Investigate the Effect of Dapagliflozin and Saxagliptin on HbA1c in Patients With Type 2 Diabetes and CKD

Efficacy and Safety of Semaglutide Once-weekly Versus Exenatide ER 2.0 mg Once-weekly as add-on to 1-2 Oral Antidiabetic Drugs (OADs) in Subjects With Type 2 Diabetes

Promoting the Universal Medication Schedule Via Mobile and EHR Technologies

A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c

Post Approval Study of the TS Feature With the 530G Pump System Supplemented With Commercial Patient Data

Dose-finding of Semaglutide Administered Subcutaneously Once Daily Versus Placebo and Liraglutide in Subjects With Type 2 Diabetes

A 6-month Clinical Study to Evaluate the Effect of a Digital Disease Management Tool in Patients With T2DM

Safety and Efficacy of Relamorelin Administered to Participants With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis

Evaluate the Efficacy and Safety of Insulin in Patients With Type 2 Diabetes

Efficacy and Safety of Faster-acting Insulin Aspart Compared to NovoRapid® Both in Combination With Insulin Degludec in Children and Adolescents With Type 1 Diabetes

A Study to Evaluate BMS-986036 in Obese Adults With Type-2 Diabetes

A Trial Investigating the Efficacy and Safety of Insulin Degludec in Children and Adolescents With Type 1 Diabetes Mellitus

A Clinical Trial Assessing The Impact Of Inhaled Insulin On Glucose Control In Patients With Type 2 Diabetes Mellitus

Hybrid Closed Loop Pivotal Trial in Type 1 Diabetes

A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)

A Study to Evaluate the Safety of THR-149 in Subjects With Diabetic Macular Edema (DME)

A Study Comparing the Effects and Safety of Dulaglutide With Insulin Glargine in Type 2 Diabetes Mellitus

A Study to Compare the Effect of a Double Dose of Two Long-acting Insulin Therapies in Participants With Type 2 Diabetes

Other Conditions in Chicago